The Affect Of An Anti-Embolism Stocking Protocol
1 other identifier
interventional
40
1 country
1
Brief Summary
This study was conducted to determine the effect of anti-embolism stocking (AES) use protocol affected the development of early venous thromboembolism (VTE) in patients undergoing total knee arthroplasty (TKA). The randomized controlled single-blind intervention study included 40 patients (Experimental Group: 20, Control Group: 20) who underwent TKA surgery in a university hospital's Orthopedics and Traumatology clinic between 2019 and 2021. While the experimental group received the AES protocol one day before the operation and continued until the 10 th day after the operation, the control group received AES on the 0 th day after the operation and remained in the patient until the 21st day after the operation. In the study, a "Data Collection Form" with DVT and PE signs and symptoms was used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 17, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 17, 2021
CompletedFirst Submitted
Initial submission to the registry
November 16, 2022
CompletedFirst Posted
Study publicly available on registry
September 27, 2024
CompletedSeptember 27, 2024
September 1, 2024
1.3 years
November 16, 2022
September 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Distribution of Descriptive Characteristics and Surgical Information of the Patients
The mean age of the experimental group was 68.6±7.1 years (range: 51-81 years) and the mean age of the control group was 68.5±8.8 years (range: 57-89 years). There was chronic disease in 90% of the experimental group, and the rate of chronic disease in the control group was 60%. Mobility status of the experimental group 1 day before the surgery; 65% (n:13) were independent, 15% (n:3) self-supported and 20% (n:4) needed help. Mobility status of the control group 1 day before the surgery; 60% (n:11) were independent, 40% (n:8) self-supported, and 5% (n:1) needed help. Mobility status of the experimental group after surgery; 10% (n:2) were independent, 90% (n:18) were self-sufficient. Mobility status in the control group; 20% (n:4) were independent, 75% (n:15) were self-sufficient and 5% (n:1) needed help. All patients in the experimental and control groups used low molecular weight heparin or anticoagulants before surgery.
Three weeks
VTE Evaluation Form
It consists of 19 questions covering symptoms of VTE, DVT and PE.
Three weeks
Secondary Outcomes (1)
The Use of Anti Embolism Stocking Protocol
Two weeks
Study Arms (2)
Experimental Group
EXPERIMENTALAES was redressed within the 21st day after the operation
Control Group
NO INTERVENTIONThe AES was dressed within the 10st day after the operation remained in the patient until the sutures
Interventions
To prevent patients undergoing TKA surgery from being affected by one another, the patients were hospitalized in separate rooms, and the orthopedic clinic team was made aware of the situation. The patients in the control group were told not to remove their socks until the sutures were removed after the operation, whereas the patients in the experimental group were told to remove their socks on the 10th day after the operation, so the patients had no idea which group they were in.
Eligibility Criteria
You may qualify if:
- Older than 18 years old,
- No harm in wearing AES,
- Patients who agreed to participate in the study.
You may not qualify if:
- Bilateral TKA used patients,
- Having excess leg edema, pulmonary edema, heart failure,
- Having leg ischemia,
- Having skin graft,
- An open wound in the area where AES will be applied,
- Having arterial and venous vessel disease,
- Having neuropathy,
- Having cellulite on the patient's leg to whom AES will be applied,
- Having an infection such as fasciitis or panniculitis,
- Those who declare that they will not use AES for ten days in accordance with the recommendations.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cukuruvo University
Adana, Sarıcam/Adana, 01330, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Sevilay ERDEN, Assoc.Prof.
Ç.Ü Faculty of Health Sciences Department of Surgical Nursing
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- To prevent patients undergoing TKA surgery from being affected by one another, the patients were hospitalized in separate rooms, and the orthopedic clinic team was made aware of the situation. The patients in the control group were told not to remove their socks until the sutures were removed after the operation, whereas the patients in the experimental group were told to remove their socks on the 10th day after the operation, so the patients had no idea which group they were in.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- specialist nurse
Study Record Dates
First Submitted
November 16, 2022
First Posted
September 27, 2024
Study Start
October 16, 2019
Primary Completion
February 17, 2021
Study Completion
February 17, 2021
Last Updated
September 27, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share